Personalis Inc. (NASDAQ: PSNL)
$2.04
+0.4250 ( +26.40% ) 1.1M
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Market Data
Open
$2.04
Previous close
$1.61
Volume
1.1M
Market cap
$104.40M
Day range
$1.58 - $2.18
52 week range
$0.89 - $2.43
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Nov 07, 2023 |
| 10-q | Quarterly Reports | 72 | Nov 07, 2023 |
| 4 | Insider transactions | 1 | Nov 03, 2023 |
| 8-k | 8K-related | 12 | Aug 28, 2023 |
| 10-q | Quarterly Reports | 72 | Aug 08, 2023 |
| 8-k | 8K-related | 14 | Aug 08, 2023 |
| 4 | Insider transactions | 1 | Aug 02, 2023 |
| 4 | Insider transactions | 1 | Aug 02, 2023 |